TP53 and neoplasm: As opposed to the well-described inhibition of various proteostatic components [13,31], in this study, we wanted to assess whether the activation of the cellular heat shock response would also lead to reduced levels of accumulated, mutant and/or aggregated p53 in tumor cells.